Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Share-based Compensation (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Share-based Compensation for 16 consecutive years, with $532000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Share-based Compensation rose 65.73% year-over-year to $532000.0, compared with a TTM value of $1.7 million through Sep 2025, up 54.34%, and an annual FY2024 reading of $1.3 million, up 38.63% over the prior year.
  • Share-based Compensation was $532000.0 for Q3 2025 at Rockwell Medical, up from $382000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $532000.0 in Q3 2025 and bottomed at -$236000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $254789.5, with a median of $309000.0 recorded in 2023.
  • The sharpest move saw Share-based Compensation tumbled 125.24% in 2021, then skyrocketed 218.56% in 2023.
  • Year by year, Share-based Compensation stood at $385000.0 in 2021, then crashed by 42.86% to $220000.0 in 2022, then decreased by 0.91% to $218000.0 in 2023, then soared by 75.23% to $382000.0 in 2024, then skyrocketed by 39.27% to $532000.0 in 2025.
  • Business Quant data shows Share-based Compensation for RMTI at $532000.0 in Q3 2025, $382000.0 in Q2 2025, and $445000.0 in Q1 2025.